UBS Group’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,100
Closed -$179K 8028
2018
Q4
$179K Hold
5,100
﹤0.01% 5042
2018
Q3
$167K Hold
5,100
﹤0.01% 5199
2018
Q2
$158K Buy
+5,100
New +$146K ﹤0.01% 5116
2017
Q3
Sell
-2,800
Closed -$92K 7910
2017
Q2
$92K Buy
+2,800
New +$92.6K ﹤0.01% 5224
2015
Q1
Sell
-600
Closed -$23K 9180
2014
Q4
$23K Buy
+600
New +$22.7K ﹤0.01% 7442

Other funds holding OHI

UBS Group's OHI Position: Q2 2026 in Review

UBS Group increased its Omega Healthcare (OHI) stake by 53% in Q2 2026, buying an estimated $36.3M and bringing the position to 2,253,738 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #1070.

UBS Group first reported a position in OHI in Q4 2014 and has held it in 47 quarters since. 762 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • UBS Group held 2,253,738 shares of Omega Healthcare worth $107M as of Q2 2026.
  • UBS Group bought 783,102 Omega Healthcare shares in Q2 2026, an estimated $36.3M.
  • Omega Healthcare made up 0.01% of UBS Group's portfolio in Q2 2026, its #1070 holding.
  • UBS Group first reported a position in Omega Healthcare in Q4 2014 and has held it in 47 quarters since.
  • 762 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.